Cargando…
Management of Hepatocellular Carcinoma: Current Status and Future Directions
Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide. This cancer commonly arises against a background of chronic liver disease. As a result, a patient with HCC requires multidisciplinary care. Treatment options vary widely based on tumor burden and metastases. Th...
Autores principales: | Au, Jennifer S., Frenette, Catherine T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gut and Liver
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477987/ https://www.ncbi.nlm.nih.gov/pubmed/26087860 http://dx.doi.org/10.5009/gnl15022 |
Ejemplares similares
-
Development of Tivantinib as Treatment for Hepatocellular Carcinoma
por: Au, Jennifer, et al.
Publicado: (2013) -
Erratum: Management of Hepatocellular Carcinoma: Current Status and Future Directions
Publicado: (2015) -
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
por: Perisetti, Abhilash, et al.
Publicado: (2022) -
Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
por: Lee, Hye Won, et al.
Publicado: (2020) -
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
por: Okusaka, Takuji, et al.
Publicado: (2018)